Global & Australia Laparoscopic Devices Market to 2031

The laparoscopic devices market in Australia is showing steady growth, supported by a robust healthcare system, increasing use of minimally invasive surgical methods, and an aging population with a rising incidence of chronic illnesses that often require surgical treatment. Among product segments, robot-assisted systems are experiencing the fastest growth. Bariatric surgeries are performed in significant numbers in Australia, with nearly all conducted laparoscopically. In 2023, there were 15,985 primary bariatric procedures, with sleeve gastrectomy comprising about 80% of these cases, while Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB) made up the rest. Although complication rates remain low (around 1.5% for sleeve gastrectomy within 90 days), only about 5% of these surgeries occur within the public healthcare sector, highlighting the dominance of private healthcare providers.

In general surgery, although detailed national data for laparoscopic procedures in 2023–2024 is not yet fully available, general surgery remains the most frequent specialty linked to elective surgeries in public hospitals, accounting for 20% of all surgeries during this period. The number of admissions from elective surgery waitlists in public hospitals rose by 5.8% to 778,500 in 2023–2024, reflecting a return to pre-pandemic levels. Many common general surgeries, such as cholecystectomies and hernia repairs, are now routinely performed laparoscopically due to their proven advantages. Laparoscopic techniques are also well-established in colorectal surgery for both benign and malignant diseases. Data from 2011 to 2021 on colorectal cancer surgery patients admitted to Australian ICUs show that 83.5% of these admissions were elective, with laparoscopic procedures being common. Globally, 40–50% of colorectal resections for benign and malignant conditions are now done laparoscopically. Recent meta-analyses up to January 2024 continue to evaluate outcomes of robotic versus laparoscopic approaches for colon cancer, illustrating ongoing refinement in minimally invasive surgery. Additionally, a March 2024 retrospective study on laparoscopic surgery for intestinal deep endometriosis in Australia reported a 0% conversion rate to open surgery, underscoring advanced surgical expertise.

In gynecology, laparoscopic devices play a crucial role in Australia. Laparoscopic hysterectomy was the highest revenue-generating procedure in 2022, and diagnostic laparoscopic procedures are among the fastest-growing segments. Conditions such as uterine fibroids and endometriosis contribute to rising demand for laparoscopic myomectomy and hysterectomy. The use of robotic-assisted laparoscopic devices is also expanding rapidly in gynecological surgeries, where they represent a significant application area.

Overall, Australia’s healthcare system strongly favors minimally invasive surgery, fueling consistent demand for advanced laparoscopic devices and technologies. Continued investments in healthcare infrastructure and technological innovation are expected to sustain the growth of the laparoscopic devices market across multiple surgical specialties in the country. Show more